Articles Referencing BCR
Bard Beats on 1Q Earnings, Profit Slumps - Analyst Blog
4/24/2013, 9:09 am from Zacks.com in Investing, Business, Earnings, Stocks
CR Bard Inc. 's ( BCR ) first-quarter
2013 adjusted earnings of $1.44 per share beat the Zacks Consensus
Estimate by a penny. Adjusted earnings exclude one-time items such
as... Read >>
C.R. Bard, Inc. (BCR) Ex-Dividend Date Scheduled for April 25, 2013
4/24/2013, 9:00 am from NASDAQ.com News in News Headlines, Stocks
C.R. Bard, Inc. ( BCR ) will begin
trading ex-dividend on April 25, 2013. A cash dividend payment of
$0.2 per share is scheduled to be paid on May 10, 2013.
Shareholders who purchased BCR stock... Read >>
After-Hours Earnings Report for April 23, 2013 : AAPL, T, AMGN, NSC, BRCM, FTI, EW, JNPR, BCR, SLG, RE, OII
4/23/2013, 2:00 pm from NASDAQ.com News in News Headlines, Earnings
The following companies are expected to report earnings after
hours on 04/23/2013. Visit our Earnings
Calendar for a full list of expected earnings releases. Apple Inc. ( AAPL ) is... Read >>
Will CR Bard Miss Earnings this Quarter? - Analyst Blog
4/22/2013, 3:11 pm from Zacks.com in Investing, Business, Earnings, Stocks
CR Bard Inc. ( BCR ) is set to report
first-quarter 2013 results after the market closes on Tuesday, Apr
23. Let's see how things are shaping up prior to the
announcement.
In the last... Read >>
Yacktman Fund - Texas Billionaire Guru Adds and Sells First Quarter
4/12/2013, 4:06 pm from GuruFocus in Investing
Investor Guru and self-made billionaire Donald Yacktman once said, "Back in 1987, the
day of the 500-point decline, I started buying like crazy ... I
spent $40 million that day."... Read >>
CR Bard Reiterated at Neutral - Analyst Blog
3/14/2013, 2:11 pm from Zacks.com in Investing, Business, Stocks
On Mar 13, we retained Neutral recommendation on CR Bard
Inc. ( BCR
) following its fourth-quarter results. Despite the upbeat results,
the company's organic growth rate, especially in the... Read >>
CR Bard Squarely Beats Estimates - Analyst Blog
2/1/2013, 11:19 am from Zacks.com in Investing, Business, Stocks
CR Bard Inc. 's ( BCR ) fourth-quarter
2012 adjusted earnings of $1.70 per share beat the Zacks Consensus
Estimate of $1.67 (flat year-over-year). Adjusted earnings exclude
one-time items... Read >>
After-Hours Earnings Report for January 31, 2013 : CB, ED, WYNN, EMN, PFG, BCR, CPT, ESS, FBHS, N, DRE, PKI
1/31/2013, 2:00 pm from NASDAQ.com News in News Headlines, Earnings
The following companies are expected to report earnings after
hours on 01/31/2013. Visit our Earnings
Calendar for a full list of expected earnings releases. Chubb Corporation ( CB ) is... Read >>
Earnings Preview: CR Bard Inc. - Analyst Blog
1/30/2013, 12:00 pm from Zacks.com in Investing, Business, Earnings, Stocks
CR Bard Inc. ( BCR ) is set to report
its fourth-quarter 2012 results after the market closes on
Thursday, Jan 31. Let's see how things are shaping up prior to the
announcement. In the... Read >>
Teleflex Wins GPO Agreement - Analyst Blog
1/22/2013, 2:50 pm from Zacks.com in Investing, Business, Stocks
Teleflex Incorporated ( TFX ), a global
provider of medical devices used in critical care and surgery,
recently won a new agreement with HealthTrust, a healthcare group
purchasing... Read >>
Covidien Wins FDA Approval - Analyst Blog
1/22/2013, 2:30 pm from Zacks.com in Investing, Business, Stocks
International health care product major, Covidien
plc. ( COV
) recently revealed approval from the Food and Drug Administration
("FDA") for Gablofen (baclofen injection) in... Read >>
Covidien Begins SWIFT PRIME Study - Analyst Blog
1/15/2013, 6:10 pm from Zacks.com in Investing, Business, Stocks
International health care product major, Covidien
plc. ( COV
), has initiated a new study, SWIFT PRIME. The main objective of
this study is to find out the efficacy of the Solitaire... Read >>
C.R. Bard, Inc. (BCR) Ex-Dividend Date Scheduled for January 17, 2013
1/15/2013, 9:00 am from NASDAQ.com News in News Headlines, Stocks
C.R. Bard, Inc. ( BCR ) will begin
trading ex-dividend on January 17, 2013. A cash dividend payment of
$0.2 per share is scheduled to be paid on February 01, 2013.
Shareholders who purchased... Read >>
Covidien Closes CV Ingenuity Buyout - Analyst Blog
1/11/2013, 12:10 pm from Zacks.com in Investing, Business, Stocks
Large-cap medical technologies company, Covidien
plc. ( COV
) has successfully completed the acquisition of Fremont,
California-based medical device company, CV Ingenuity. Both the
parties... Read >>
ANGO Beats on EPS, Tweaks View - Analyst Blog
1/4/2013, 8:28 am from Zacks.com in Investing, Business, Stocks
AngioDynamics Inc. ( ANGO )
reported adjusted earnings of 10 cents per share for the second
quarter of fiscal 2013 ended November 30, 2012, beating the Zacks
Consensus Estimate by a penny... Read >>